As the antibacterial drug market continues to expand, pharmaceutical companies are accelerating the deployment of innovative drugs
Time of Update: 2021-12-25
For example, Zai Lab's two new class 1 drugs, omacycline tosylate tablets and omacycline tosylate for injection, were approved for marketing, becoming the fourth and fifth systemic antibacterial innovative drugs approved this year .
Seventy-three varieties conform to the fourth batch
Time of Update: 2021-03-02
Previously, the Health Insurance Bureau in the future collection also named biological products (including insulin), Chinese medicine, the number of varieties eligible for collection conditions or its amount reached a certain level, that is, trigger the start of national harvesting, is expected to carry out two batches per year.
The lowest price in a batch of 9 provinces was made public
Time of Update: 2020-08-24
(5) In addition to (1), drugs that meet the reporting requirements of item (2) and drugs with the original collection platform to determine the drug trading platform in accordance with the enterprise's declared price and annual procurement volume, the declared price shall not be higher than the national minimum 9 provinces average price (excluding the medical insurance payment price or the purchase price with volume), the undeclared as abandoned the winning bid hanging network qualification.
New migraine drug! Teva/Otsuka Japan submits Ajovy listing application, Teva/Takeda Japan joint venture sells generic drug assets
Time of Update: 2020-08-06
"This is an exciting milestone that will deliver on our global mission to improve patients' lives by advancing potential new treatments," said Gianfranco Nazzi, executive vice president of Teva International Markets.
Clinical Trends of China's Class 1 New Drugs in May 2020
Time of Update: 2020-08-01
In May 2020, a total of 19 Chinese class 1 chemical drugs were approved by the State Drug Administration (NMPA) for clinical trials, the specific information is shown in the table below: data sources: Pharmaceutical Spyu Database01, SPH4336 SPH-4336 developed by Shanghai Pharmaceuticals, in the clinical phase of the treatment of advanced solid tumors.
Two joint anti-tumor therapies approved for dofencin, the pioneer drug of the xenon generation
Time of Update: 2020-07-10
Guide: Clinical research on the treatment of a variety of malignant tumors by Doafeni is under way July 9, Zeyan Pharmaceuticals issued two corporate announcements, saying that its company recently r
Second domestic PD-1 pricing announcement
Time of Update: 2019-03-06
On February 22, Cinda biology announced that cindilimab injection (trade name: Dabusu) was officially launched into the domestic market More than ten days later, Dabusu's pricing was officially announ
4 + 7 list of pharmaceutical enterprises that may be involved in centralized drug procurement in cities
Time of Update: 2018-11-21
On November 15, 2018, the centralized procurement document of 4 + 7 urban drugs was issued, the first order of medical insurance procurement, and the two words at the core of the document: "quantity"
List of Changzhou second bargaining shortlisted
Time of Update: 2016-07-15
Source: on July 14, 2017-7-15, the notice of Jiangsu Province on publishing the shortlisted products of 2016 emergency (emergency) rescue and non patent medical institutions of women and children's sp
Eprazole sodium for injection is expected to complete the third phase of clinical research in June next year
Time of Update: 2014-11-05
Alprazole sodium for injection is a dosage form upgrade project of alprazole enteric coated tablets Tao Desheng, vice president of the company, once said that on the basis of effective promotion of th